To isolate and evaluate α-glucosidase inhibitors from dichloromethane extract of Croton bonplandianum Baill as probable remedy for management of diabetes. Methods: Activity-guided isolation of constituents from dichloromethane extract was carried out. Fractionation of dichloromethane extract by column chromatography on silica gel and Sephadex LH 20 using different mobile phase systems led to the isolation of compounds (A-I). The structures of these isolated compounds were established by ultraviolet (UV) and infrared (IR) spectroscopy. Proton nuclear magnetic resonance ( 1 H NMR), 13 C NMR and mass spectrophotometry, electron impact mass spectroscopy (EIMS) and high resolution mass spectroscopy (HRMS) were used for structural elucidation. All the isolated compounds were screened for their α-glucosidase inhibitory activity using standard in vitro α-glucosidase inhibition assay. Acarbose was used as positive control. Results: On the basis of their physical and spectral data from literature, the isolated compounds were identified , GandI possessed significant α-glucosidase inhibitory activity in a concentration-dependent manner with 50 % inhibitory concentration (IC50) values ranging from 23.0 to 26.7 μg/mL, relative to that of the positive control, acarbose (IC50, 38.2 µg/mL). Conclusion: The plant contains bioactive compounds with α-glucosidase inhibitory activity. This lendssome support for the traditional use of this herb in the management of diabetes. Compound F, GandI possessed significant α-glucosidase inhibitory activity in a concentration-dependent manner and may be developed as a new α-glucosidase inhibitor.
INTRODUCTION
Croton bonplandianum Baill (Euphorbiaceae) is a monoecious woody shrub, which is 1 -5 meter high with whorled branches. The plant grows in sandy clay soil along roadsides, irrigation canal banks, in plantations and on waste ground [1] . It has been reported that this plant grows in South Balivia, Paraguay, South West Brazil, North Argentina, Bangladesh, South America, South India and Pakistan [2] . In Pakistan, this plant is found near Khyber, Attock, Wah, Rawalpindi, Sargodha, Gujarat, Sialkot, Lahore and Karachi. Among the medicinal benefits of plants, antioxidant properties have received increasing attention due to their role in preventing or downregulating myriads of oxidative damages caused by free radicals in the body [3] . Oxidative stress is initiated by free radicals, which seek stability through electron pairing with biological macromolecules such as proteins, lipids and DNA in healthy human cells and cause protein and DNA damage along with lipid peroxidation. These changes contribute to cancer, atherosclerosis, cardiovascular diseases, ageing and inflammatory diseases [4] . Preliminary screening study revealed that the dichloromethane extract of Croton bonplandianum exhibited significant α-Glucosidase inhibition activity of 97.89 % with 50 % inhibitory concentration (IC 50 ) of 14.93 mg/ml while acarbose (reference) exhibited 92.23 % inhibition with IC 50 of 38.25 mg/ml [5] . Therefore, further phytochemical investigation of Croton bonplandianum is necessary to ascertain its suitability as a medicinal food for postprandial hyperglycemia linked to diabetes mellitus.
EXPERIMENTAL Plant material
The plant material was collected from Sargodha District, Pakistan. The plant was identified as Croton bonplandianum by Professor Dr Altaf Ahmad Dasti taxonomist, Institute of Pure and Applied Biology, Bahauddin Zakariya University, Multan and a voucher specimen (no. SWT-446) was deposited at the herbarium of Institute of Pure and Applied Biology, Bahauddin Zakariya University, Multan, Pakistan. 
Chemicals, reagents and instrumentation

Extraction and isolation of compounds (A-I)
For the purpose of effective extraction, whole plant material was shade-dried for 15 days. Then dried plant material was ground in blender and weighed.
The extraction of this finely ground material was affected by simple maceration. An amount (800 g) was taken in an extraction bottle and measured volume of dichloromethane (1500 ml) was added to it. Ultrasonication of this mixture was carried out occasionally in order to achieve maximum possible extraction. Filtration was carried out after 24 h of addition of solvent. The process was repeated three times with dichloromethane. The extraction of the plant material was done by methanol in the same manner. The dichloromethane and methanol extracts were concentrated separately under reduced pressure using a rotary evaporator. After the extraction process, 20.2 g of dichloromethane and 48.9 g of methanol extracts were obtained. The extracts were collected in separate sample bottles and designated CBWPD and CBWPM, respectively.
Isolation of compound from dichloromethane extract
Dichloromethane extract (18 g) was subjected to column chromatography on silica gel using stepwise elution with n-hexane-ethyl acetate ((80:20 →70:30 → 60:40 → 50:50 →ethylacetate) in increasing order of polarity. six fractions (CBWPD 1-CBWPD 6) were obtained. The fraction CBWPD 2 (4.07g) subjected to column chromatography on silica gel using nhexane-ethylacetate (80:20 →70:30) as eluent resulted two fractions (2a and 2b). The fraction 2a (1400 mg) was subjected to column chromatography on silica gel using n-hexaneethylacetate (60:40) as eluent which gave two pure compounds A (11 mg) and B (9 mg). The fraction CBWPD-3 (3.10g) was subjected to column chromatography on silica gel using nhexane-ethylacetate (80:20 →70:30) as eluent resulted two fractions (3a and 3b). The fraction 3a (1200 mg) was subjected to column chromatography on silica gel using n-hexaneethylacetate (60:40) as eluent which gave two pure compounds C (12 mg) and D (14 mg).The fraction CBWPD-4 (2.74g) obtained by n-hexaneethyl acetate (80:20 →70:30) was subjected to column chromatography on silica gel using nhexane -EtOAc (60:40) as eluent resulted two fractions (4a and 4b). The fraction 4a (850 mg) was subjected to column chromatography on silica gel using n-hexane -EtOAc (60:40) as eluent which gave two pure compounds E (8 mg) and F (6 mg). The fraction CBWPD-5 (1.0g) was subjected to column chromatography on silica gel using ethylacetate-methanol (80:20 →70:30) as eluent resulted two fractions (5a and 5b). The fraction 5a (500 mg) was subjected to column chromatography on silica gel hexane -EtOAc (60:40) as eluent which gave two pure compounds G (7 mg) and H (6 mg). Fraction 5b (50 mg) was subjected to column chromatography on Sephadex LH-20 using methanol as eluent afforded compound I (9 mg). The structures of these isolated compounds were established by spectroscopic technique such as UV and IR spectroscopy. Proton Nuclear Magnetic Resonance ( 1 H NMR), 13 C NMR and Mass spectrophotometry (EIMS, HRMS) were used for elucidation of structure. Isolation scheme of compounds (A-I) from dichloromethane extract of whole plant of croton bonplandianum (CBWPD) is given in Figure 1 . 
In vitro α-glucosidase inhibition assay
The α-glucosidase inhibitory activity was assessed by a standard method [6] , with slight modifications. A volume of 60 μl of sample solution and 50 μL of 0.1 M phosphate buffer (pH 6.8) containing α-glucosidase solution (0.2 U/mL) was incubated in 96 well plates at 37 ºC for 20 min. After pre-incubation, 50 μL of 5 mM pnitrophenyl-α-D-glucopyranoside (PNPG) solution in 0.1 M phosphate buffer (pH 6.8) was added to each well and incubated at 37 ºC for another 20 min. The reaction was stopped by adding 160 μl of 0.2 M NaCO 3 to each well, and absorbance readings were recorded at 405 nm by micro-plate reader and compared to control which had 60 μL of buffer solution in place of the extract. For blank incubation (to allow for absorbance produced by the extract), enzyme solution was replaced by buffer solution and absorbance recorded.
The concentrations of test compounds which inhibited the hydrolysis of substrates by 50 % (IC 50 ) were determined by monitoring the effect of decreasing concentrations of these extracts in the assays on the inhibition values. IC 50 values were then calculated using EZ-Fit Enzyme Kinetics program (Perrella Scientific Inc., Amherst, USA).
Statistical analysis
All data were analyzed by analysis of variance (ANOVA) and mean values were compared by Duncan's Multiple Range Tests using SPSS software, version 15 (SPSS Inc, Chicago, IL, USA). P < 0.05 was considered statistically significant.
RESULTS
Isolation of compound (A-I)
Dichloromethane extract was subjected to a series of column and flash chromatographic techniques as described in the experimental to obtain nine compounds reported for the first time from this species. These are identified as of npentacosanyl-n-nonadeca-7′-en-9′-α-ol-1′-oate (A), n-tridecanyl n-octadec-9,12-dienoate (B), nonacosyl hexadecanoate (C), heptacosanoic acid (D), 1,3,5-trihydroxy-2-hexadecanoylamino-(6e,9e)-heptacosdiene (E), cumarin (F), betulin (G), stigmasterol (H), and 3,5-dimethoxy 4hydroxy cinnamic acid (I) respectively, on the basis of their spectral data, structure of isolated compound are given in Figure 2 .
n-Pentacosanyl-n-nonadeca-7′-en-9′-α-ol-1′oate (A)
White amphorous powder (11 mg The physical and spectral data showed complete resemblance with the those reported in the literature [14] [15] .
3,5-dimethoxy 4-hydroxy cinamic acid (I)
Yellow solid from acetone (15 mg [16] .
In vitro α-glucosidase inhibition
All the isolated compounds were screened for αglucosidase inhibitory activity. Compound 2H-1-Benzopyran-2-one (F), Betulin (G) & 3, 5-Dimethoxy 4-hydroxy cinnamic acid (I) possessed significant α-glucosidase inhibitory activity in a concentration-dependent manner, and showed more potent inhibitory activity, with IC 50 values ranging from 23.0 to 26.7 μM, than that of a positive control acarbose (IC 50 , 38.2 μM). Results are summarized in Table 1 .
DISCUSSION
Diabetes is one of the world's greatest health problems, affecting about 171 million people and most of these will be dominated by those suffering from type II diabetes [17] . One of the strategies to monitor blood glucose for type II diabetes mellitus is to either inhibit or reduce the production of glucose from the small intestine. Diet rich in carbohydrate causes sharp rise in the blood glucose level as the complex carbohydrates in the food is rapidly absorbed in the intestine aided by the α-glucosidase enzyme which breaks disaccharides into absorbable monosaccharides, α-glucosidase inhibitor inhibits the disaccharide digestion and impedes the postprandial glucose excursion to enable overall smooth glucose profile [18] . Thus, natural products of great structural diversity are still a good source for searching for such inhibitors, thereby motivating to explore biologically active compounds from the highly diverse plants.
The development of the alpha-glucosidase inhibitor provides a new approach in the management of diabetes. By competitive and reversible inhibition of intestinal alphaglucosidases, alpha-glucosidase delays carbohydrate digestion, prolongs the overall carbohydrate digestion time, and thus reduces the rate of glucose absorption. After oral administration of alpha-glucosidase, the postprandial rise in blood glucose is dosedependently decreased, and glucose-induced insulin secretion is attenuated. Due to diminished postprandial hyperglycemia and hyperinsulinemia by alpha-glucosidase inhibitor, triglyceride uptake into adipose tissue, hepatic lipogenesis, and triglyceride content are reduced. Therefore, alpha-glucosidase inhibitor treatment not only flattens postprandial glycemia, due to the primary and secondary pharmacodynamic effects, but also ameliorates the metabolic state in general.
Thus, alpha-glucosidase inhibitor may have the potential to delay or possibly prevent the development of diabetic complications [19] . Compound 2H-1-Benzopyran-2-one (F), Betulin (G) & 3, 5-Dimethoxy 4-hydroxy cinnamic acid (I) possessed significant α-glucosidase inhibitory activity in a concentration-dependent manner, and showed more potent inhibitory activity, with IC 50 values ranging from 23.0 to 26.7 μM, than that of a positive control acarbose (IC 50 , 38.2 μM). It has been displayed that these compounds are attractive candidates for αglucosidase inhibitory activity.
CONCLUSION
In the light of these findings, the isolated compounds exhibited inhibitory activity against αglucosidase in a dose-dependent manner and therefore may potentially be developed as new α-glucosidase inhibitors for the treatment of type 2 diabetes.
